Evidence map›Paper›PMID 38858395›Full record

ArticleScientific reports2024

Heterogeneous gene expression during early arteriovenous fistula remodeling suggests that downregulation of metabolism predicts adaptive venous remodeling.

Yuichi Ohashi, Clinton D Protack, Yukihiko Aoyagi, Luis Gonzalez, Carly Thaxton, Weichang Zhang, Masaki Kano, Hualong Bai, Bogdan Yatsula, Rafael Alves and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuichi OhashiVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Clinton D ProtackVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Yukihiko AoyagiVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Luis GonzalezVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Carly ThaxtonVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Weichang ZhangVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Masaki KanoVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Hualong BaiVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Bogdan YatsulaVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Rafael AlvesVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Katsuyuki HoshinaDivision of Vascular Surgery, Department of Surgery, The University of Tokyo, Tokyo, Japan.
Eric B SchneiderDepartment of Surgery, Center for Health Services and Outcomes Research, Yale School of Medicine, New Haven, CT, USA.
Xiaochun LongVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Rachel J PerryDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Alan DardikVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA. alan.dardik@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Manipulating the matrix to improve arteriovenous fistula patencyR01HL144476 · NHLBI · YALE UNIVERSITY · PI Alan Dardik · 2019 to 2026
$5.6M
Adaptive immunity regulates arteriovenous fistula remodelingR01HL162580 · NHLBI · YALE UNIVERSITY · PI Alan Dardik · 2023 to 2026
$3.0M
Molecular control of vascular smooth muscle reprogramming in arteriovenous fistula maturationR01DK135284 · NIDDK · AUGUSTA UNIVERSITY · PI Alan Dardik, Xiaochun Long · 2023 to 2026
$2.8M
Vascular Smooth Muscle Protein Quality Control and Aortic Aneurysm FormationR01HL170024 · NHLBI · AUGUSTA UNIVERSITY · PI Xiaochun Long, Chen Yan · 2023 to 2026
$2.7M
Role of endothelial Sox17 in EC-SMC crosstalk and homeostatic regulation of blood vessel adaption to arterial hemodynamicsR01HL162908 · NHLBI · NORTHEASTERN UNIVERSITY · PI DAI, GUOHAO, DARDIK, ALAN · 2022 to 2025
$2.3M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL144476NHLBI NIH HHS R01 HL162580NHLBI NIH HHS R01 HL162908NHLBI NIH HHS R01 HL170024NIDDK NIH HHS R01 DK135284NIH HHS R01-DK135284NIH HHS R01-HL144476
6 · The paper itself

Abstract

Clinical outcomes of arteriovenous fistulae (AVF) for hemodialysis remain inadequate since biological mechanisms of AVF maturation and failure are still poorly understood. Aortocaval fistula creation (AVF group) or a sham operation (sham group) was performed in C57BL/6 mice. Venous limbs were collected on postoperative day 7 and total RNA was extracted for high throughput RNA sequencing and bioinformatic analysis. Genes in metabolic pathways were significantly downregulated in the AVF, whereas significant sex differences were not detected. Since gene expression patterns among the AVF group were heterogenous, the AVF group was divided into a 'normal' AVF (nAVF) group and an 'outliers' (OUT) group. The gene expression patterns of the nAVF and OUT groups were consistent with previously published data showing venous adaptive remodeling, whereas enrichment analyses showed significant upregulation of metabolism, inflammation and coagulation in the OUT group compared to the nAVF group, suggesting the heterogeneity during venous remodeling reflects early gene expression changes that may correlate with AVF maturation or failure. Early detection of these processes may be a translational strategy to predict fistula failure and reduce patient morbidity.

Indexed as

Arteriovenous Shunt, SurgicalMice, Inbred C57BLVascular RemodelingAnimalsArteriovenous FistulaDown-RegulationFemaleGene Expression ProfilingGene Expression RegulationMaleMiceRenal DialysisVeins

Identifiers

PMID38858395
PMCPMC11164895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.